Items where Author is "Jahnke, Wolfgang"

2022

Jahnke, Wolfgang and Paladini, Johannes and Habazettl, Judith M. and Wiget, Andrea and Loo, Alice and Cowan Jacob, Sandra W. and Grzesiek, Stephan and Manley, Paul W.. (2022) Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase". Angewandte Chemie International Edition, 61 (46). e202117276.

2013

Skora, Lukasz and Mestan, Jürgen and Fabbro, Doriano and Jahnke, Wolfgang and Grzesiek, Stephan. (2013) NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors. Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, H. 47 , E4437-E4445.

2010

Zhang, Jianming and Adrián, Francisco J. and Jahnke, Wolfgang and Cowan-Jacob, Sandra W. and Li, Allen G. and Iacob, Roxana E. and Sim, Taebo and Powers, John and Dierks, Christine and Sun, Fangxian and Guo, Gui-Rong and Ding, Qiang and Okram, Barun and Choi, Yongmun and Wojciechowski, Amy and Deng, Xianming and Liu, Guoxun and Fendrich, Gabriele and Strauss, André and Vajpai, Navratna and Grzesiek, Stephan and Tuntland, Tove and Liu, Yi and Bursulaya, Badry and Azam, Mohammad and Manley, Paul W. and Engen, John R. and Daley, George Q. and Warmuth, Markus and Gray, Nathanael S.. (2010) Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature, Vol. 463, H. 7280. pp. 501-506.

2008

Vajpai, Navratna and Strauss, André and Fendrich, Gabriele and Cowan-Jacob, Sandra W. and Manley, Paul W. and Jahnke, Wolfgang and Grzesiek, Stephan. (2008) Backbone NMR resonance assignment of the Abelson kinase domain in complex with imatinib. Biomolecular NMR Assignments, 2 (1). pp. 41-42.

Vajpai, Navratna and Strauss, André and Fendrich, Gabriele and Cowan-Jacob, Sandra W. and Manley, Paul W. and Grzesiek, Stephan and Jahnke, Wolfgang. (2008) Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinib. Journal of biological chemistry, 283 (26). pp. 18292-18302.